IRIS UniCatt

Citterio, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.891
NA - Nord America 6.563
AS - Asia 4.574
SA - Sud America 904
AF - Africa 193
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 10
Totale 28.150
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.049
US - Stati Uniti d'America 6.415
SG - Singapore 2.274
DE - Germania 1.129
CN - Cina 963
BR - Brasile 741
NL - Olanda 738
SE - Svezia 652
UA - Ucraina 533
FR - Francia 482
VN - Vietnam 380
IE - Irlanda 268
GB - Regno Unito 225
IN - India 182
PL - Polonia 175
FI - Finlandia 167
ID - Indonesia 166
JP - Giappone 126
RU - Federazione Russa 122
TR - Turchia 77
ES - Italia 76
CA - Canada 69
CH - Svizzera 67
HK - Hong Kong 65
BD - Bangladesh 64
IQ - Iraq 63
AR - Argentina 54
CI - Costa d'Avorio 52
BE - Belgio 48
MX - Messico 46
ZA - Sudafrica 39
IR - Iran 28
MA - Marocco 26
SA - Arabia Saudita 23
VE - Venezuela 23
AT - Austria 21
PK - Pakistan 21
EC - Ecuador 20
CO - Colombia 18
KE - Kenya 18
CL - Cile 17
AL - Albania 15
CZ - Repubblica Ceca 15
EG - Egitto 15
PH - Filippine 14
RO - Romania 13
UZ - Uzbekistan 13
AU - Australia 12
BG - Bulgaria 12
AE - Emirati Arabi Uniti 11
KR - Corea 11
TN - Tunisia 11
GR - Grecia 10
JM - Giamaica 10
LT - Lituania 10
IL - Israele 9
NP - Nepal 9
DZ - Algeria 8
PY - Paraguay 8
TH - Thailandia 8
TW - Taiwan 8
UY - Uruguay 8
AZ - Azerbaigian 7
JO - Giordania 7
MY - Malesia 7
PE - Perù 7
PT - Portogallo 7
ET - Etiopia 6
HU - Ungheria 6
KZ - Kazakistan 6
SI - Slovenia 6
SK - Slovacchia (Repubblica Slovacca) 6
BH - Bahrain 5
DK - Danimarca 5
HN - Honduras 5
KG - Kirghizistan 5
NO - Norvegia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BO - Bolivia 4
GE - Georgia 4
MD - Moldavia 4
NG - Nigeria 4
NI - Nicaragua 4
OM - Oman 4
RS - Serbia 4
SM - San Marino 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CV - Capo Verde 3
GT - Guatemala 3
GY - Guiana 3
IS - Islanda 3
NZ - Nuova Zelanda 3
PA - Panama 3
QA - Qatar 3
A1 - Anonimo 2
AM - Armenia 2
BB - Barbados 2
CR - Costa Rica 2
EE - Estonia 2
Totale 28.115
Salva come PNG Salva come JPEG
Città #
Singapore 1.104
Milan 1.083
Chandler 1.028
Rome 772
Ashburn 612
San Jose 565
Naples 352
Dublin 254
Jacksonville 248
San Mateo 246
Beijing 235
New York 217
Turin 207
Florence 173
Wilmington 163
Jakarta 153
Bologna 152
Palermo 134
Lauterbourg 133
Ho Chi Minh City 129
Nanjing 129
Ann Arbor 127
Boston 124
Hanoi 116
Bari 113
Fairfield 111
Catania 105
Los Angeles 103
Tokyo 101
Genoa 97
Warsaw 96
Lawrence 94
Cattolica 93
Dearborn 79
Verona 74
Redwood City 67
Houston 66
Moscow 66
Frankfurt am Main 63
Dallas 60
Chicago 59
Brescia 58
The Dalles 58
Hong Kong 57
Princeton 54
Seattle 54
São Paulo 54
Abidjan 52
Kraków 50
Nürnberg 49
Woodbridge 48
Buffalo 46
Padova 45
Hefei 44
Munich 44
Parma 41
Helsinki 40
Orem 40
Venice 40
Guangzhou 39
Nanchang 39
Bergamo 38
Cagliari 38
Brussels 37
Reggio Emilia 37
Santa Clara 37
Taranto 37
Pescara 36
Redmond 35
Rio de Janeiro 35
Mountain View 34
Messina 33
Perugia 33
Madrid 32
Boardman 29
Hangzhou 29
Lancaster 29
San Francisco 29
Livorno 28
London 28
Paris 28
Shenyang 28
Norwalk 27
University Park 27
Brooklyn 26
Izmir 26
Amsterdam 25
Augusta 25
Hebei 25
Lucca 25
Salerno 25
Toronto 24
Marseille 23
Modena 23
Monza 23
Rimini 23
Bremen 22
Belo Horizonte 21
Changsha 21
Kunming 21
Totale 11.977
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 11.973
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: results from a preliminary cross-sectional study 193
Accidental transplantation of a kidney with stones: case report 192
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney 188
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 185
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation 181
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors. 181
Contrast-enhanced Voiding US for Grading of Reflux in Adult Patients Prior to Antireflux Ureteral Implantation1 174
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 172
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results 171
HIGH-DOSE ATORVASTATIN REDUCE OXIDATIVE STRESS OF ISCHEMIA/REPERFUSION INJURY AFTER ISOGENEIC KIDNEY TRANSPLANTATION IN RATS 169
Effects of Switching from Twice-Daily to Once-Daily Tacrolimus Formulation on Quality of Life, Anxiety, and Transplant Benefit Perception after Kidney Transplantation 168
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 164
LAPDOCTOR: TELL ME HOW DIFFICULT WILL BE MY DONOR 164
Early Appearance of De Novo Anti-HLA Antibodies Following Renal Transplantation: Preliminary Results of a Prospective Multicenter Study. 159
Belatacept utilization recommendations: an expert position 155
Significant improvement in patient survival after renal transplantation in the last decade. 152
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 150
COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VERSUS LCPT 148
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 147
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 146
RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES 145
Living Kidney Donation in a Type 1 Dent's Disease Patient from His Mother 145
CHYLOUS ASCITES AFTER LAPAROSCOPIC LIVING DONOR NEPHRECTOMY. CASE REPORT AND REVIEW OF THE LITERATURE 145
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results. 142
Preoperative Psychological Factors Predicting Graft Rejection in Patients Undergoing Kidney Transplant: A Pilot Study 141
INCIDENCE AND RISK FACTORS FOR DE-NOVO CANCERS IN ITALIAN KIDNEY TRANSPLANT (KT) RECIPIENTS 137
Complete clinical remission of psoriasis 6 months after renal transplantation 137
Interventional radiological treatment of renal transplant complications: a pictorial review 137
Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation 136
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 136
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 136
AN EASY ALGORITHM TO OPTIMIZE THE EXPOSURE TO TACROLIMUS AND EVEROLIMUS, WHEN USED IN COMBINATION 134
Perioperative-, recipient-, and donor-related factors affecting delayed graft function in kidney transplantation 133
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 132
Extended-Release Tacrolimus Plus Everolimus or Micophenolate Mofetil in Deceased Donor Kidney Transplant Recipients: 6-Month Results of a Prospective Randomized Clinical Trial 130
TO TRANSPLANT OR NOT TO TRANSPLANT: A KIDNEY WITH A GIANT CYST. CASE REPORT AND REVIEW OF THE LITERATURE 130
Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms 129
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 128
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 128
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 128
Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts 127
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: Results from a preliminary cross-sectional study 127
How Challenging Will Be My Living Donor? CT Scan and Clinical Evaluation Can Predict Technical Difficulty of Laparoscopic Donor Nephrectomy 126
Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 124
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 123
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 123
Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT 123
PRELIMINARY RESULTS FROM A PROSPECTIVE MULTICENTER STUDY REVEAL THE EARLY APPEARANCE OF DE NOVO ANTI-HLA ANTIBODIES FOLLOWING RENAL TRANSPLANTATION 122
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 122
Andamento temporale di alcune proteine della fase acuta dopo trapianto di rene 121
Interventional Radiological Treatment of Renal Transplant Complications: A Pictorial Review 119
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy. 118
Evaluation of Everolimus Activity against Mycobacterium tuberculosis Using In Vitro Models of Infection 115
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 115
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 115
Anonymity and live-donor transplantation: an ELPAT view 115
[Nitrogen loss after kidney transplantation: effects of immunosuppressive therapy] 115
COVID-19 and kidney transplantation: an Italian Survey and Consensus 115
Behavioural and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 114
Emotional management and quality of life in mother living versus multi-organ donor renal transplant recipients 113
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 112
Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help? 111
"Why can't I give you my organs after my heart has stopped beating?" An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy 111
Global Kidney Exchange: opportunity or exploitation? An ELPAT/ESOT appraisal 111
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 110
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 110
The Relevance of Directive 2010/53/EU for Living Organ Donation Practice: An ELPAT View 109
Radiofrequency thermal ablation of renal graft neoplasms: A literature review 109
De Novo Malignancies after Organ Transplantation: Focus on Viral Infections 108
Evolution of causes of mortality in renal transplantation in the last 10 years 108
Belatacept utilization recommendations: an expert position 107
Spontaneous renal allograft rupture complicated by urinary leakage: case report and review of the literature 107
ONE-SHOT VERSUS MULTIDOSE PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS AFTER KIDNEY TRANSPLANTATION: A RANDOMIZED, CONTROLLED, CLINICAL TRIAL 107
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study 106
Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial 106
Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients 106
Isoprinosine effects on postoperative immunodepression 104
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors 104
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-year results of a pilot study 103
Prediction, prevention, and management of delayed graft function: where are we now? 103
Process control: simply a matter of efficiency or of survival and costs? A single-centre quality improvement project in living donor renal transplant 102
Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study 102
Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study 102
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies 101
Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study 101
Wound Healing Complications and the Use of Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation: A Critical Review of the Literature 100
Dealing With Public Solicitation of Organs From Living Donors-An ELPAT View 100
Everolimus and Minimization of Cyclosporine in Renal Transplantation: 24-Month Follow-Up of the EVEREST Study 99
Dealing With Public Solicitation of Organs From Living Donors--An ELPAT View 99
Belatacept utilization recommendations: an expert position 98
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation 95
[Organ transplantation: training and prospects for a young surgeon] 95
Surgical Antibiotic Prophylaxis After Renal Transplantation: Time to Reconsider. 95
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study 95
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009 94
Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation 94
Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study 93
Immunosoppressive Therapy and Risk of Post-Transplant Malignancies after Kidney Transplantation: Italian Multicentric Study 93
Raising awareness of unspecified living kidney donation: An ELPAT 93
Totale 24.436
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.875
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021198 0 0 0 0 0 0 0 0 0 0 176 22
2021/20221.336 84 125 27 52 46 55 37 227 49 98 267 269
2022/20233.797 332 348 192 452 177 432 152 343 495 203 385 286
2023/20244.961 284 576 300 374 340 488 402 417 349 444 487 500
2024/20257.190 492 664 689 565 691 508 517 589 823 439 662 551
2025/20267.085 1.199 335 492 641 1.191 398 1.189 477 520 529 114 0
Totale 28.345